Immune-mediated diseases affect 1 in 10 people. The last two decades have seen advances in treatment, but today too many patients still struggle to manage their symptoms, cycling through treatment options while the disease irreversibly progresses. At AstraZeneca, we are focusing on translating our deep understanding of the underlying biology driving immune dysfunction to advance a wide range of potential new options, with the aim of making remission and one day, cure a reality in these diseases. Learn more about our work in immunology: https://www.astrazeneca.com/our-therapy-areas/respiratory-and-immunology/immunology.html This video was produced and funded by AstraZeneca. ------------------------------------------------------------ Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: X (Twitter): https://twitter.com/AstraZeneca LinkedIn: https://www.linkedin.com/company/astrazeneca/ Instagram: https://www.instagram.com/astrazeneca/ Facebook: https://www.facebook.com/astrazenecacareers/

 287